- Home
- EVGN vs ADIL Comparison
EVGN vs ADIL Comparison
Compare EVGN & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVGN | ADIL |
|---|---|---|
| Founded | 1999 | 2010 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1M | 11.4M |
| IPO Year | 2013 | 2017 |
Fundamental Metrics
Financial Performance| Metric | EVGN | ADIL |
|---|---|---|
| Price | $0.40 | $3.46 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.33 |
| AVG Volume (30 Days) | ★ 297.9K | 38.3K |
| Earning Date | 11-19-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $81.06 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.35 | $0.13 |
| 52 Week High | $1.33 | $9.75 |
Technical Indicators
Market Signals| Indicator | EVGN | ADIL |
|---|---|---|
| Relative Strength Index (RSI) | 39.55 | 40.00 |
| Support Level | $0.36 | $2.38 |
| Resistance Level | $0.86 | $4.94 |
| Average True Range (ATR) | 0.04 | 0.42 |
| MACD | 0.00 | -0.06 |
| Stochastic Oscillator | 24.73 | 31.33 |
Price Performance
Historical ComparisonAbout EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.